Projects per year
Collaborations and top research areas from the last five years
Profiles
-
Floor Abbink
- CCA - Cancer biology and immunology (VUmc) - Medical Specialist
- CCA - Treatment and quality of life (VUmc) - Medical Specialist
- AII - Cancer immunology (VUmc) - Medical Specialist
- Paediatric (VUmc) - Medical Specialist
Person: Academic
-
Hella Aberson
- Center of Experimental and Molecular Medicine (AMC) - Support Staff
- AII - Cancer immunology (AMC) - Support Staff
- AII - Inflammatory diseases (AMC) - Support Staff
- CCA - Cancer biology and immunology (AMC) - Support Staff
Person: Academic
-
Pierre Agnass
- Doctoral School - Standard PhD Candidate
- CCA - Cancer Treatment and Quality of Life (AMC) - Standard PhD Candidate
- CCA - Imaging and biomarkers (AMC) - Standard PhD Candidate
- AII - Cancer immunology (AMC) - Standard PhD Candidate
- CCA - Cancer biology and immunology (AMC) - Standard PhD Candidate
- Amsterdam Gastroenterology Endocrinology Metabolism (AMC) - Standard PhD Candidate
Person: Academic
-
LYMPHOMACHIPTHERA: Development of a lymphoma-on-chip model for testing therapeutic strategies
1/02/2024 → 31/05/2025
Project: Research
-
KWF Young Investigator Grant - Targeting fibroblastic stroma to disrupt the diffuse large B-cell lymphoma niche
1/06/2023 → 31/05/2027
Project: Research
-
FUCOSYLATED GLYCAN EPITOPES AS NOVEL IMMUNE CHECKPOINT MOLECULES IN COLORECTAL CANCER
van Vliet, S., van Kooyk, Y., van Egmond, M. & Hatinguais, R.
1/06/2023 → 31/05/2026
Project: Research
Research output
-
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial
Kater, A. P., Arslan, Ö., Demirkan, F., Herishanu, Y., Ferhanoglu, B., Diaz, M. G., Leber, B., Montillo, M., Panayiotidis, P., Rossi, D., Skarbnik, A., Tempescul, A., Turgut, M., Mellink, C. H., van der Kevie-Kersemaekers, A-M. F., Lanham, S., Sale, B., del Rio, L., Popovic, R., Chyla, B. J., & 7 others , 1 Apr 2024, In: The Lancet Oncology. 25, 4, p. 463-473 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Scopus) -
Adaptive immune changes associate with clinical progression of Alzheimer's disease
van Olst, L., Kamermans, A., Halters, S., van der Pol, S. M. A., Rodriguez, E., Verberk, I. M. W., Verberk, S. G. S., Wessels, D. W. R., Rodriguez-Mogeda, C., Verhoeff, J., Wouters, D., Van den Bossche, J., Garcia-Vallejo, J. J., Lemstra, A. W., Witte, M. E., van der Flier, W. M., Teunissen, C. E. & de Vries, H. E., 24 Apr 2024, In: Molecular Neurodegeneration. 19, 1, p. 38Research output: Contribution to journal › Article › Academic › peer-review
-
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
Campanella, A., Capasso, A., Heltai, S., Taccetti, C., Albi, E., Herishanu, Y., Haggenburg, S., Chatzikonstantinou, T., Doubek, M., Kättström, M., Giannopoulos, K., Simkovic, M., Moreno, C., Massaia, M., Bumbea, H., Alshemmari, S., Ranghetti, P., Perotta, E., Martini, F., Sant'Antonio, E., & 24 others , Apr 2024, In: American journal of hematology. 99, 4, p. 745-750 6 p.Research output: Contribution to journal › Letter › Academic › peer-review
Open Access
Datasets
-
Additional file 8 of Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer
Buikhuisen, J. (Creator), Gomez Barila, P. M. (Creator), Cameron, K. (Creator), Suijkerbuijk, S. J. E. (Creator), Lieftink, C. (Creator), di Franco, S. (Creator), Krotenberg Garcia, A. (Creator), Uceda Castro, R. (Creator), Lenos, K. (Creator), Nijman, L. E. (Creator), Torang, A. (Creator), Longobardi, C. (Creator), de Jong, J. (Creator), Dekker, D. (Creator), Stassi, G. (Creator), Vermeulen, L. (Creator), Beijersbergen, R. L. (Creator), van Rheenen, J. (Creator), Huveneers, S. (Creator) & Medema, J. P. (Creator), Figshare, 2023
DOI: 10.6084/m9.figshare.22626329.v1, https://springernature.figshare.com/articles/dataset/Additional_file_8_of_Subtype-specific_kinase_dependency_regulates_growth_and_metastasis_of_poor-prognosis_mesenchymal_colorectal_cancer/22626329/1
Dataset
-
Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade
Cloherty, A. (Creator), Rader, A. (Creator), Patel, K. S. (Creator), Pérez-Vargas, J. (Creator), Thompson, C. A. H. (Creator), Ennis, S. (Creator), Niikura, M. (Creator), Wildenberg, M. (Creator), Dijkstra - Muncan, V. (Creator), Schreurs, R. (Creator), Jean, F. (Creator) & Ribeiro, C. (Creator), Taylor & Francis, 2023
DOI: 10.6084/m9.figshare.22323729, https://tandf.figshare.com/articles/dataset/Berbamine_suppresses_intestinal_SARS-CoV-2_infection_via_a_BNIP3-dependent_autophagy_blockade/22323729
Dataset
-
Additional file 1: of A specific gene expression signature for visceral organ metastasis in breast cancer
Savci Heijink, D. (Contributor), Halfwerk, H. (Contributor), Koster, J. (Contributor) & Horlings, H. M. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.7967798, https://springernature.figshare.com/articles/Additional_file_1_of_A_specific_gene_expression_signature_for_visceral_organ_metastasis_in_breast_cancer/7967798
Dataset
Prizes
-
-
Germline genetic biomarker to predict metastatic risk in melanoma patients.
Ouwerkerk, Wouter (Recipient), 28 Nov 2023
Prize › Academic
-
Personalized treatment decisions based on genetic profile in melanoma patients about to receive immunotherapy.
Ouwerkerk, Wouter (Recipient), 31 Jul 2018
Prize › Academic
Activities
-
NVVI Spring Meeting 2024
Lotte de Winde (Participant)
21 Mar 2024Activity: Participating in or organising an event › Organising a conference, workshop, ... › Academic
-
Dutch Cancer Foundation (External organisation)
Marjolein van Egmond (Member)
1 Jan 2024 → …Activity: Membership › Membership of board › Academic
-
Pigment Cell & Melanoma Research (Journal)
Rosalie Luiten (Member of editorial board)
1 Apr 2024 → 1 Apr 2026Activity: Peer review and Editorial work › Publication peer-review
Press/Media
-
Verzamelen en uitwisselen van DNA-data voor kankertherapie op maat
14/02/2024
1 Media contribution
Press/Media: Interview
-
TV interview Tijd voor Max over immuuntherapie van kanker
2/11/2023
1 Media contribution
Press/Media: Press / Media
-
Interview tijdschrift ‘Kijk over immuuntherapie van kanker
1/11/2023
1 Media contribution
Press/Media: Press / Media